The risk of ILD was highest within the first 2 years after IBD diagnosis (aHR 2.14, 95% CI 1.51-3.05) but remained ...

Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...

Large cohort study finds interstitial lung disease independently increases lung cancer risk across all major subtypes, even ...

Pune: Infantry soldier Tariq Aziz (30) is set to return to active duty after undergoing a bilateral lung transplant — the ...

Liquidia rallied for a third straight day on Tuesday, ending 13.68 percent higher at $24.10 as investor sentiment was bolstered by the higher prescription rate for its newly approved pulmonary ...

Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according ...

Abatacept is linked to lower mortality and fewer hospitalizations than rituximab in patients with rheumatoid ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...

Liquidia Q2 sales hit $8.84 million after Yutrepia launch; PH-ILD study shows stable tolerability and improved walking ...

Inhalational exposures to smoking, asbestos, dust, metals, and organics significantly increase the odds of developing interstitial lung disease.

Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.